3006.93.10.00/Blinded Placebo Aspirin Tablets for Migraine Trial/Japan

Blinded Placebo Aspirin Tablets for Migraine Trial from Japan

These are inert placebo tablets identical in appearance to aspirin, packaged with actual aspirin medicinal preparations in blinded kits for a recognized clinical trial on migraine relief. They fall under HTS 3006.93.10.00 as placebos put up in measured doses, packaged alongside medicinal preparations for double-blinded studies. This ensures neither participants nor researchers know who receives the active drug.

Duty Rate — Japan → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Obtain FDA Investigational New Drug (IND) approval and provide clinical trial protocol documentation to Customs for clearance

• Label kits clearly as 'Clinical Trial Materials - Not for Resale' to avoid misclassification as commercial medicaments

• Verify sterility certificates and measured dose packaging to prevent reclassification under general pharmaceutical headings